Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
To gain approval in the UK, the Retatrutide trial data must be reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA)
Badenhorst 2016 measured wrinkle volume reductions up to 55.8% and depth reductions of 32.8% over 12 weeks of topical use
We support our patients and their goals, whether they choose to stay on a maintenance dose or transition off the medication
These represent areas requiring careful clinical assessment rather than definitive UK contraindications, as formal eligibility criteria for retatrutide cannot yet be established in the absence of regulatory approval
A previous allergic reaction, such as a rash, swelling, or difficulty breathing, is an absolute contraindication to retatrutide
US$ 28.18
US$ 28.92
US$ 23.40
